Suchergebnisse - "Smith, Kenneth J"

PubPharm (12)

1

Investigation into the Cost-Effectiveness of Extended Posttraumatic Thromboprophylaxis

enthalten in: Journal of the American College of Surgeons | 2022

von Nicholson, K. | Rosengart, M. | Smith, K. | +2

2

Cost-Utility Analysis of Apixaban versus Warfarin in Atrial Fibrillation Patients with Chronic Kidney Disease

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2018

von Altawalbeh, S. | Alshogran, O. | Smith, K.

3

Comparing the Cost Effectiveness of Non-vitamin K Antagonist Oral Anticoagulants with Well-Managed Warfarin for Stroke Prevention in Atrial Fibrillation Patients at High Risk of Bleeding

enthalten in: American journal of cardiovascular drugs : drugs, devices, and other interventions | 2018

von Hospodar, A. | Smith, K. | Zhang, Y. | +1

4

Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation at high risk of bleeding and normal kidney function

enthalten in: Thrombosis research | 2017

von Hernandez, I. | Smith, K. | Zhang, Y.

5

Cost-effectiveness of rivaroxaban versus warfarin anticoagulation for the prevention of recurrent venous thromboembolism : a U.S. perspective

enthalten in: Thrombosis research | 2013

von Seaman, C. | Smith, K. | Ragni, M.

6

Anticoagulation duration in heterozygous factor V Leiden : a decision analysis

enthalten in: Thrombosis research | 2013

von Donovan, A. | Smith, K. | Ragni, M.

7

Anticoagulation in ambulatory cancer patients with no indication for prophylactic or therapeutic anticoagulation : a cost-effectiveness analysis from a U.S. perspective

enthalten in: Thrombosis and haemostasis | 2012

von Pishko, A. | Smith, K. | Ragni, M.

8

Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement : a systematic review

enthalten in: PharmacoEconomics | 2010

von Kapoor, A. | Chuang, W. | Radhakrishnan, N. | +5

CommentIn: Pharmacoeconomics. 2010;28(9):781-2; author reply 782-4, 784-5. - PMID 20824908

9

Using thrombophilia testing to determine anticoagulation duration in pediatric thrombosis is not cost-effective

enthalten in: The Journal of pediatrics | 2009

von O'Brien, S. | Smith, K.

10

Should female relatives of factor V Leiden carriers be screened prior to oral contraceptive use? A cost-effectiveness analysis

enthalten in: Thrombosis and haemostasis | 2008

von Smith, K. | Monsef, B. | Ragni, M.